In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants might be enrolled at the recognized monotherapy dosign routine. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will likely be presented as "increase-on" therapy. In Phase C, https://abbv-744-therapeutic-pote24679.blog-kids.com/32146044/about-abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc